CYRX (Cryoport, Inc.) Forward P/E Multiple

Cryoport, Inc. (CYRX) develops IT solutions to optimize product flows, utilizing contract electronics manufacturing and cloud-based shipment monitoring for the biopharma sector. The confirmed price history on this chart reflects a Forward P/E level of 0.00. The expansion of commercial cell therapies creates powerful operating leverage, allowing for a significant reduction in unit transportation costs as cryogenic infrastructure volumes grow.

cryoport.com - CYRX Market Cap to Future Earnings Ratio (period 07/04/2022 - 11/14/2026)

Financial and market metric breakdowns for Cryoport Corp (CYRX)

- current price and projected stock value:

Stock Quotes Cryoport|CYRX - Fair Value Consensus

- business market valuation indicators:

Market Capitalization Cryoport Inc|CYRX - Company Buyout Price

- book capitalization information:

Accounting Value per Share Cryoport|CYRX - Total Net Assets|Market Capitalization to Book Value Ratio cryoport.com|CYRX - Cumulative Company Assets

- debt and liquidity details:

- financial results and valuation multiples details:

CYRX - Company Net Income|Expected Profit Cryoport, Inc.|CYRX - Company Value to Net Income|Projected Price to Earnings Cryoport Systems|CYRX - Company Value to Earnings Growth Ratio|Enterprise Value to EBITDA Ratio Cryoport Inc|CYRX - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Cryoport|CYRX - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months cryoport.com|CYRX - Earnings per share growth this year|Earnings growth forecast for next year Cryoport, Inc.

- company sales and revenue statistics:

CYRX - Company Sales|Company Future Sales Volume Cryoport|CYRX - Price-to-Revenue Coefficient|Forward P/S Multiple Cryoport Inc

Analysis of all company metrics:CYRX Cryoport

The specifics of Cryoport, Inc. (CYRX) biomaterial logistics and its inherent project volatility make the company's forward P/E dynamics a key valuation tool. This metric determines the market value of one dollar of expected earnings, with the calculation based on dividing the current share price by the forward EPS. A declining ratio amid stable flows signals that the asset is undervalued, and it is critical for investors to correlate this trend with clinical trial cycles.

Competitors of Cryoport, Inc. (CYRX)